---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-121331"
form_type: "8-K"
ticker: "OBIO"
cik: "0001814114"
company_name: "Orchestra BioMed Holdings, Inc."
filed_at: "2023-11-28T23:59:59+00:00"
generated_at: "2026-06-07T21:07:21.941490+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Orchestra BioMed amends registration rights agreement, delaying S-1 amendment and effectiveness deadlines

## Summary
- Obligation to amend S-1 deferred to earlier of April 1, 2024 or 15 business days after filing 2023 10-K.
- Effectiveness deadline pushed to 90 days after filing first amendment or 10 business days after SEC clearance.
- Amendment involves Medtronic affiliate Covidien Group S.à.r.l. and other investors.
- Replaces the prior amended registration rights agreement from January 2023.

## SEC filing metadata
- accession: 0001104659-23-121331
- form_type: 8-K
- ticker: OBIO
- cik: 0001814114
- company_name: Orchestra BioMed Holdings, Inc.
- filed_at: 2023-11-28T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1814114/000110465923121331/0001104659-23-121331-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1814114/000110465923121331/tm2331589d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-121331
- JSON: https://secwatch.observer/filing/0001104659-23-121331.json
- Plain text: https://secwatch.observer/filing/0001104659-23-121331.txt

## Key facts
- Material Agreements
  Orchestra BioMed Holdings, Inc. amended Second Amended and Restated Registration Rights and Lock-Up Agreement with Covidien Group S.à.r.l. valued at Delayed obligation to amend registration statement and cause effectiveness (effective 2023-11-21).
  - Action: amendment
  - Counterparty: Covidien Group S.à.r.l.
  - Value: Delayed obligation to amend registration statement and cause effectiveness
  - Effective: 2023-11-21
  source text: On November 21, 2023, Orchestra BioMed Holdings, Inc. (the “Company”) entered into a Second Amended and Restated Registration Rights and Lock-Up Agreement with certain investors named therein (the “Amended Agreement”), which amended and restated the Amended and Restated Registration Rights and Lock-Up Agreement, dated January 26, 2023 (the “Original Agreement”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1814114/000110465923121331/0001104659-23-121331-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.